Share on LinkedInShare on LinkedIn

ARTICLE · 06 JUNE 2024

Market Intelligence Thought Leadership Award Winner

Patent Law In Türkiye Key Developments And Predictions - 2024

Gün + Partners
Gün + Partners
Contributor
Gün + Partners

Gün + Partners

We are one of the oldest and largest law firms in Turkey and are considered internationally to be...

View firm profile
Explore more from Gün + Partners

As Turkish patent law strides into 2024, it is met with a landscape brimming with innovation, regulatory shifts, and strategic challenges.

TurkeyIntellectual Property
Mehmet Gün
Mehmet Gün
Aysel Korkmaz Yatkın
Aysel Korkmaz Yatkın
Ozge Atilgan Karakulak
Ozge Atilgan Karakulak
Selin Sinem Erciyas
Selin Sinem Erciyas
Zeynep Çağla Üstün
Zeynep Çağla Üstün
Aysu Eryaşar
Aysu Eryaşar
Fatma Sevde Tan
Fatma Sevde Tan
Beste Turan
Beste Turan
Author LinkedIn connections

As Turkish patent law strides into 2024, it is met with a landscape brimming with innovation, regulatory shifts, and strategic challenges. This overview distills critical insights and developments, guiding our interested readers through the intricate fabric of this evolving legal domain.

The conversation around AI and inventorship heralds a new era for intellectual property, challenging traditional boundaries and prompting a reevaluation of legal frameworks both in Turkey and globally. This issue dovetails with the transformative EU pharmaceutical legislative reforms, creating a dual front where technological and regulatory changes demand agile and forward-thinking legal strategies. The emphasis on protecting the valuation and market position of original pharmaceutical products through legal innovations like partial preliminary injunctions is particularly poignant, reflecting a proactive approach to navigating competitive markets.

The EU pharmaceutical legislative reforms specifically address the Bolar issue and seek to expand the scope of the "Bolar Exemption." However, it is crucial to ensure that this expansion remains consistent with the law and the interests of all involved parties. In Turkish legal practice, challenges have arisen due to courts interpreting the Bolar Exemption more broadly than the provision's intended scope, creating difficulties for patent owners. Despite these challenges, recent optimism has emerged from a judicial decision that aligns with the law and balances the interests of both parties. This decision suggests a potential shift towards a fairer system, providing hope for improved clarity and fairness in the implementation of the Bolar Exemption in Turkish pharmaceutical law.

The anticipation of the Unified Patent Court (UPC) and the escalation of tactical patent invalidation tactics represent significant considerations for patent strategy and litigation, underscoring the need for a dynamic and informed response to protect intellectual assets. These developments underscore the importance of adaptability and strategic foresight in upholding patent rights and navigating legal complexities.

The dialogue on Standard-Essential Patents (SEPs) further illustrates the nuanced interplay between innovation promotion and intellectual property protection. This discussions reflect a broader trend towards reconciling the imperatives of technological advancement with the principles of fair access and competition, especially within the pharmaceutical sector.

A noteworthy advancement in the legal landscape is the evolving approach to compensating damages for unfair preliminary injunction decisions, marking a progressive shift towards equity and justice in the pharmaceutical industry. This change is emblematic of a broader movement towards more balanced and fair legal practices in patent law.

This overview presents a holistic view of the challenges and opportunities within Turkish patent law in 2024, characterized by a dynamic interplay between legal innovation, regulatory adaptation, and strategic litigation. For in-house legal counsels, these insights underscore the critical importance of an integrated approach to intellectual property management, legal strategy, and regulatory compliance.

CONTENTS

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from